LncRNA-SRA1 Suppresses Osteosarcoma Cell Proliferation While Promoting Cell Apoptosis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Osteosarcoma is a prevalent bone malignancy in children and adolescents.
• Understanding the molecular mechanisms underlying osteosarcoma progression is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the expression and biological function of long noncoding RNA-steroid receptor RNA activator 1 (SRA1) in osteosarcoma.
• To explore the regulatory mechanism of SRA1, particularly its interaction with microRNA-208a, in osteosarcoma progression.
• To assess the potential of SRA1 as a diagnostic marker and therapeutic target for osteosarcoma.

Main Methods:

• Microarray analysis and quantitative real-time polymerase chain reaction (qRT-PCR) to determine SRA1 and microRNA-208a expression levels.
• Transfection of osteosarcoma cell lines with constructs to modulate SRA1 expression (pcDNA3.1-SRA1, pCMV-sh-SRA1) and microRNA-208a inhibitors/mimics.
• Cell Counting Kit-8, colony formation assays, flow cytometry, wound-healing, and transwell assays to evaluate cell proliferation, apoptosis, migration, and invasion.

Main Results:

• SRA1 expression was significantly downregulated in osteosarcoma tissues and cells compared to normal tissues.
• microRNA-208a expression was upregulated in osteosarcoma tissues.
• Restoration of SRA1 inhibited osteosarcoma cell proliferation, migration, and invasion, while enhancing apoptosis.
• SRA1 directly targets microRNA-208a, and this interaction is critical for osteosarcoma progression.

Conclusions:

• SRA1 exhibits antitumor properties in osteosarcoma by suppressing proliferation, migration, and invasion, and promoting apoptosis.
• The SRA1-microRNA-208a axis plays a significant role in osteosarcoma development.
• SRA1 represents a promising therapeutic target for osteosarcoma treatment.